2Wang JN,Yao CT,Yeh CN,et al. Critical management in patients with severe enterovirus 71 infection[J]. Pediatr Int,2006,48(3):250-256.
3Chang LY,Lin TY,Hsu KH,et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand,foot,and mouth disease[J]. Lancet, 1999,354(9191) : 1682-1686.
4Prager P,Nolan M,Andrews lP,et al. Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivom[J]. Pediatr Crit Care Med,2003,4(3):377-381.
5Wang SM,Lei HY,Huang MC,et al. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema[J]. Pediatr Pulmonol,2005,39(3) :219-223.
9Yan JJ, Su IJ, Chen PF, et al. Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J Med Virol, 2001,65:331-339.
10Oberste MS, Maher K, Kilpatrick DR, et al. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol, 1999,73:1941-1948.
8Zhuang D, 1-Iu W, Ren H, et al. The influences of temperature on spatiotemporal trends of hand-foot-and-mouth disease in China's Mainland[J].Int J Environ Health Res, 2014, 24(1):1-10. DOI: 10.1080/09603123.2013.769206.
9Chen J, Fu Y, Ju L, et al. Detection and identification of viral pathogens in patients with hand, foot, and mouth disease by multilocus PCR, reverse- transcription PCR and electrospray ionization mass spectrometry[J].J Clin Virol, 2014, 59(2):115-119. DOI:10.1016/j.jcv.2013.11.007.
10Tan CW, Lai JK, Sam IC, et al. Recent developments in antiviral agents against enterovirus 71 irffeetion[J].J Biomed Sci, 2014, (21):14. DOI:10.1186/1423-0127-21-14.
